Market Research Report
Global Hemostasis Valve Market 2019-2025
|Published by||Orion Market Research Pvt Ltd||Product code||888712|
Delivery time: 2-3 business days
|Global Hemostasis Valve Market 2019-2025|
|Published: July 3, 2019||Content info:||
Hemostasis Valve Market Size, Share & Trends Analysis Report, by Type (Y-Connector, Double Y-Connector, and One-Handed), by Application (Angiography and Angioplasty), and Forecast, 2019-2025.
Hemostasis valve is designed to reduce blood loss during the interventional procedure. It works on continuous sealing mechanism during positioning of microcatheter and wire in order to reduce blood loss and blood stagnation under the guide catheter. The crucial factors surging the demand for hemostasis valve include rising demand for catheter-based procedures coupled with a significant prevalence of cardiovascular diseases (CVDs). For instance, the total number of open-heart surgeries performed by 54 hospitals in New Jersey was 9,147 in 2018. The total number of cardiac diagnostics procedures performed was 68,032 and total PCI (Percutaneous Coronary Intervention) procedures performed were 28,727 in 2018 (according to the State of New Jersey). PCI procedures are performed using a catheter that enables to place a stent to open narrowed blood vessels in the heart. Hemostasis valves are used in complex PCI cases to reduce blood loss and air embolism risk and leverage patient safety for each case. In addition, it reduces back-bleeding while offering better free wire or catheter movement. Increasing focus on patients' safety is surging the demand for catheter-based procedures and thereby, contributing to the growth of the market.
Geographically, North America is estimated to hold the major share in the market due to a shifting trend towards cardiac catheterization procedure. In addition, well-developed healthcare infrastructure in the region further gives a boost to the growth of the market in North America. Moreover, Asia-Pacific is anticipated to witness optimistic growth during the forecast period due to rising prevalence of CVD coupled with increasing demand for minimally invasive procedures in the region.
Some of the major players operating in the market include Merit Medical Systems, Inc., Freudenberg Medical, LLC, Boston Scientific Inc., Teleflex, Inc., Abbott Laboratories, Inc., and B. Braun Melsungen AG. The strategies followed by these companies to expand market share and gain competitive advantage include mergers and acquisitions, product launches, and geographical expansion. For instance, in January 2017, Abbott Laboratories, Inc. acquired St. Jude Medical, Inc. The acquisition offered a significant opportunity to the Abbott Laboratories for future growth and is an essential part of the constant efforts of Abbott to develop potential, diverse portfolio of medical devices, diagnostics, and generic pharmaceuticals.
The market study of the global hemostasis valve market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
The report is intended for manufacturers of hemostasis valve, medical devices, and others, healthcare providers, government organizations, potential investors, research institutes for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, different product offerings, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insight into the market for making better business decisions.